Huntington's disease: a clinical review

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|1|24-34

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.1, 2018-01, pp. : 24-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ethyl‐eicosapentaenoic acid treatment in Huntington's disease: A placebo‐controlled clinical trial

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1426-1429

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive testing and clinical trials in Huntington's disease: An ethical analysis

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 243-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pridopidine paradox in Huntington's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1321-1324

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Coexistence and Differentiation of Late Onset Huntington's Disease and Alzheimer's Disease: A Case Report and Review of the Literature

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 36, Iss. 3, 1988-03 ,pp. : 237-242

John Wiley & Sons Inc

Access to resources Recommend Favorite

An exploratory pharmacodynamic study with selisistat in HD

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 3, 2015-03 ,pp. : 465-476

John Wiley & Sons Inc

Access to resources Recommend Favorite